Señales en vivo de GRTS | Maximiza tus Ganancias con Getagraph.com

COMPRAR 138434 min ago

@ $2.18

Emitido: 14 feb 2024 @ 14:06

Retorno: -62.40%

Señal anterior: feb 13 - 15:42

Señal anterior: Vender

Retorno: 3.82 %

Live Chart Being Loaded With Signals

Commentary (20 may 2024 @ 16:00):

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases...

Stats
Volumen de hoy	2.24M
Volumen promedio	2.98M
Capitalización de mercado	88.80M
EPS	$0 ( 2024-05-09 )
Próxima fecha de ganancias	( $-0.320 ) 2024-06-17
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.660
ATR14	$0.00400 (0.49%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-15	Allen Andrew R	Buy	47 873	Common Stock
2024-05-16	Allen Andrew R	Sell	24 263	Common Stock
2024-05-15	Allen Andrew R	Buy	615 000	Stock Option (Right to Buy)
2024-05-15	Jones Erin	Buy	27 128	Common Stock
2024-05-16	Jones Erin	Sell	13 749	Common Stock

INSIDER POWER
96.52
Last 98 transactions
Buy: 7 577 348 \| Sell: 147 493

Volumen Correlación

Largo: 0.21 (neutral)

Corto: -0.99 (very strong negative)

Signal:(45.278) Neutral

Gritstone Oncology Inc Correlación

10 Correlaciones Más Positivas
LULU	0.893
EZGO	0.89
ATNF	0.887
AFYA	0.87
SRNE	0.863
QH	0.862
ISSC	0.861
RCMT	0.856
ATRC	0.855
YI	0.854

10 Correlaciones Más Negativas
LABP	-0.936
NVEI	-0.921
CURI	-0.918
CENX	-0.918
IDN	-0.916
TH	-0.909
PAYS	-0.908
VFF	-0.898
WIRE	-0.898
STOK	-0.893

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Gritstone Oncology Inc Correlación - Moneda/Commodity

-0.07
( neutral )

0.31
( neutral )

0.00
( neutral )

-0.21
( neutral )

Gritstone Oncology Inc Finanzas

Annual	2023
Ingresos:	$1.33M
Beneficio Bruto:	$-6.26M (-470.32 %)
EPS:	$-1.200

FY	2023
Ingresos:	$1.33M
Beneficio Bruto:	$-6.26M (-470.32 %)
EPS:	$-1.200

FY	2022
Ingresos:	$9.27M
Beneficio Bruto:	$-6.42M (-69.28 %)
EPS:	$-1.240

FY	2021
Ingresos:	$48.21M
Beneficio Bruto:	$48.21M (100.00 %)
EPS:	$-0.965

Financial Reports:

No articles found.

Gritstone Oncology Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Gritstone Oncology Inc

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.